Short sellers are concentrating their bets heavily in the small-cap space as of mid-April, with healthcare, and biotechnology in particular, drawing the most attention. The following list ranks the 10 ...

Marketing claims in AI rarely survive contact with reality. That’s because making real progress in healthcare is hard. To ...

OpenAI is rolling out an early version of an artificial intelligence model designed to accelerate drug discovery, joining a ...

Recursion Pharmaceuticals, Inc. (RXRX) 25th Annual Needham Virtual Healthcare Conference April 13, 2026 12:45 PM EDTCompany ParticipantsBen Taylor - ...

According to market consultancy Frost & Sullivan, the global AI-enabled pharmaceutical R&D market is projected to grow from ...

The model will be available initially as a research preview to some of the company’s business customers, OpenAI said ...

In the latest trading session, Recursion Pharmaceuticals (RXRX) closed at $3.60, marking a -4% move from the previous day. The stock trailed the S&P 500, which registered a daily gain of 0.26%.

Each Strixhaven college gets their own dedicated ability. Silverquill's is repartee, which triggers whenever you play an ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Stryker (SYK) and Solid Biosciences (SLDB) with bullish sentiments. According to TipRanks.com, Wuensch is ...

Recursion Pharmaceuticals executives discussed the company’s artificial intelligence-driven drug discovery platform during a ...

View Recursion Pharmaceuticals, Inc. Class A RXRX stock quote prices, financial information, real-time forecasts, and company news from CNN.

Generic formats like JSON or XML are easier to version than forms. However, they were not originally intended to be ...